Radicicol: Reliable Hsp90 Inhibition in Cell Assays
2026-08-26
Learn how Radicicol (SKU A4067) can support interpretable cell viability, differentiation, and apoptosis workflows. This scenario-based guide connects product handling, assay design, potency context, and vendor-selection decisions for biomedical laboratories.
TRIM66 and the One-Neuron-One-Receptor Rule
2026-08-25
The reference study identifies TRIM66 as an epigenetic repressor that helps mature olfactory sensory neurons silence extra olfactory receptor genes after an initially polygenic phase. By linking enhancer repression to receptor singularity, neural activity, and innate olfactory behavior, the work clarifies a central step in sensory-neuron specification and provides a framework for studying cell-to-cell receptor choice.
HotStart™ 2X Green qPCR Master Mix Guide
2026-08-25
HotStart™ 2X Green qPCR Master Mix provides a practical SYBR Green workflow for detecting and quantifying DNA or cDNA while reducing amplification initiated before thermal cycling. It is suitable for real-time PCR gene expression analysis, nucleic acid quantification, and RNA-seq validation, but target-specific performance, cycling conditions, and compatibility with individual instruments must be validated experimentally.
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-08-24
The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia, extending LMO2 biology beyond its established roles in hematopoietic development and T-cell leukemia. Through loss-of-function, interaction mapping, transcriptomics, chromatin profiling, and rescue experiments, the authors connect LDB1 activity with AML-cell proliferation, survival, and apoptosis-related gene regulation.
GI 254023X: ADAM10 Inhibitor Workflows
2026-08-23
GI 254023X is a selective ADAM10 inhibitor for dissecting sheddase-dependent signaling, endothelial barrier failure, and Jurkat-cell responses. This practical guide connects target engagement with functional readouts while showing how moderate perturbation and orthogonal controls can improve assay interpretation.
TUDCA and the Galectin-1–FIP200 NAFLD Axis
2026-08-22
A mechanistic framework for using Tauroursodeoxycholic Acid to interrogate the intersection of ER stress, mitochondrial injury, autophagic flux, and insulin resistance in NAFLD research. Anchored to evidence that galectin-1 disrupts FIP200-dependent autophagy, this article positions TUDCA as a hypothesis-testing perturbation rather than a nonspecific rescue reagent, with practical guidance for translational assay design.
Developmental SSRI Exposure and Motivation Deficits
2026-08-21
A 2026 Columbia dissertation found that developmental SSRI exposure selectively impaired effortful reward seeking in adolescent and adult mice, while reward licking and Pavlovian learning were comparatively preserved. Pharmacological antagonism or nucleus accumbens knockdown of mu opioid receptors attenuated the motivational phenotype, pointing to opioid-reward circuitry as a mechanistic target distinct from repeated SSRI treatment.
VX-765: Reading Caspase-1 Assays Correctly
2026-08-20
VX-765 and its active metabolite VRT-043198 are valuable tools for dissecting caspase-1 signaling, but recent evidence reveals important assay-context limitations. This guide connects inflammasome biology with practical controls for cytokine, pyroptosis, and cross-caspase experiments.
Chlorpromazine HCl in Mechanism-First Assays
2026-08-20
Chlorpromazine HCl is more than a conventional dopamine receptor antagonist: it can serve as a calibrated pharmacological perturbation across receptor, synaptic, and cell-based experiments. This guide connects its neuropharmacology to a recent electrical-stimulation study of nanoparticle endocytosis while clearly separating established evidence from assay hypotheses.
Doxorubicin Hydrochloride: A Dual-Assay Framework
2026-08-19
Doxorubicin hydrochloride can be used to build a matched experimental framework that measures tumor-cell injury alongside cardiac stress. This article translates mechanistic evidence on ferroptosis, oxidative injury, and Nrf2/HO-1 signaling into practical assay decisions for cancer chemotherapy research.
Rottlerin PKC Inhibitor: Assay Workflows
2026-08-19
Use Rottlerin as a PKC inhibitor to connect signaling perturbation with cell proliferation inhibition, apoptosis induction, and mechanistic uptake assays. This guide adapts an ocular nanoparticle workflow into a controlled PKC-dependence experiment while emphasizing viability controls, pathway-specific readouts, and reproducibility.
CPI-613: Mechanism and Cancer Research Use
2026-08-18
CPI-613, also known as 6,8-bis(benzylsulfanyl)octanoic acid, is a lipoate-derived mitochondrial metabolism inhibitor for cancer research. Its reported PDH and KGDH activity provides a rationale for apoptosis assays, tumor cell metabolism studies, and chemotherapy-combination experiments, but preclinical findings should not be interpreted as clinical efficacy.
Acifran Workflows for GPCR Lipid Signaling
2026-08-18
Acifran enables controlled activation studies of HM74A/GPR109A and GPR109B/HCAR3 in cell-based and structure-guided research. This practical guide combines assay setup, concentration planning, receptor comparison, and troubleshooting for lipid metabolism and signaling applications.
Phosphatase Inhibitor Cocktail 2: Use & Limits
2026-08-17
Phosphatase Inhibitor Cocktail 2 is a 100X aqueous reagent for broad phosphatase suppression during sample preparation. Its defined dilution and storage specifications support protein phosphorylation preservation, but assay-specific compatibility and phosphatase coverage still require validation.
Triamcinolone: Practical Research Protocol Guide
2026-08-17
Triamcinolone (SKU B1859) provides a defined synthetic glucocorticoid agonist input for in vitro studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. Its water and ethanol insolubility, DMSO solubility, solid-state storage requirement, and research-only status must be addressed before use; it is not intended for diagnostic, therapeutic, or clinical applications.
470 records 8/32 page Previous Next First page 上5页 678910 下5页 Last page